Johnson & Johnson Presents New Data at the 2025 SVIN Annual Meeting

4 months ago 116
ARTICLE AD BOX

Johnson & Johnson has announced its scientific program for the 2025 Society of Vascular and Interventional Neurology (SVIN) Annual Meeting, taking place Nov. 19–22 in Orlando, Florida. Presentations will feature new data in chronic subdural hematoma (cSDH) and acute ischemic stroke, including a late-breaking post-hoc analysis from the MEMBRANE study, a meta-analysis of randomized controlled trials on middle meningeal artery embolization (MMAe), and new research on access approaches and aspiration technique variation.

“This year’s SVIN meeting represents an important opportunity to bring forward new evidence in both the treatment of chronic subdural hematoma and ischemic stroke, two areas where Johnson & Johnson Neurovascular is committed to advancing new treatment options,” said Christian Cuzick, Worldwide President, Johnson & Johnson MedTech Neurovascular. “With a robust scientific schedule, we’re proud to share new data on CEREGLIDE™ 92 and cyclic aspiration as we continue developing technologies that support physicians in achieving more effective outcomes for their patients.”

Johnson & Johnson MedTech Neurovascular scientific presentations at SVIN include:

Chronic Subdural Hematoma

  • MEMBRANE Post-Hoc Analysis: Vascular Penetration in Middle Meningeal Artery Embolization (MMAE) for Chronic Subdural Hematoma
    H. Shoirah | Nov. 22, 1–1:10 p.m. | Late-breaking Oral Presentation
     
  • Middle Meningeal Artery Embolization for the Treatment of Chronic Subdural Hematoma: A Meta-analysis of Randomized Controlled Trials
    M. Mirza | Nov. 20, 6–7 p.m. | Moderated Poster Presentation
     
  • Treatment Trends Among Patients With Newly Diagnosed Chronic Subdural Hematoma: A US Database Population Analysis
    E. Kottenmeier | Nov. 21, 8 a.m.–5 p.m. | Printed Poster Abstract

Ischemic Stroke

  • A Comparative Analysis of Pre-clinical and Clinical Outcomes for Cyclic and Standard Thrombo-aspiration Techniques in Acute Ischemic Stroke
    N. Moreton | Nov. 21, 8 a.m.–5 p.m. | Printed Poster Abstract
     
  • Cyclic vs. Standard Aspiration Techniques for Thrombo-aspiration in Acute Ischemic Stroke: A Comparative Analysis of Pre-clinical Outcomes
    N. Moreton | Nov. 21, 8 a.m.–5 p.m. | Printed Poster Abstract
     
  • Transradial Versus Transfemoral Access in Mechanical Thrombectomy for the Treatment of Acute Ischemic Stroke
    M.M. Perez | Nov. 21, 8 a.m.–5 p.m. | Printed Poster Abstract
  • Procedural Variations and Failure Rates in Transradial vs. Transfemoral Access for Acute Ischemic Stroke Thrombectomy
    M.M. Perez | Nov. 22, 11 a.m.–noon | Moderated Poster Presentation

Migraine & Aneurysm

  • Impact of Prophylactic Intervention on Migraine Burden: Effect on Headache Days, Migraine Days, MIDAS, and 50% Responder Rates versus Placebo
    P. Guastavino | ePoster
     
  • Outcomes Associated With The Enterprise Stent Treating Ruptured Intracranial Aneurysms: A Systematic Literature Review
    E. Kottenmeier | ePoster

Source:  Johnson & Johnson

The post Johnson & Johnson Presents New Data at the 2025 SVIN Annual Meeting appeared first on Surgical Robotics Technology.

Read Entire Article